JNK pathway‐associated phosphatase in acute ischemic stroke patients: Its correlation with T helper cells, clinical properties, and recurrence risk

• Published in: Journal of clinical laboratory analysis Vol. 36; no. 8; pp. e24535 - n/a
• Main Authors: Zhao, Ping, Huo, Huiyong, Li, Juntao, Zhang, Wenchao, Liu, Chao, Jin, Bei, Wang, Huijuan, Wang, Chaohui
• Format: Journal Article
• Language: English
• Published: New York John Wiley & Sons, Inc 01.08.2022; John Wiley and Sons Inc
• Subjects: acute ischemic stroke; Body mass index; CD4+ T cells; Cerebrovascular diseases; Cytokines; Diabetes; disease severity; Enzymes; Etiology; Flow cytometry; Helper cells; Hypertension; Immune response; Immune response (cell-mediated); Inflammation; Interferon; Ischemia; JKAP; Kidney diseases; Lymphocytes T; Medical prognosis; Mortality; Patients; Phosphatase; prognosis; Software; Stroke
• ISSN: 0887-8013; 1098-2825; 1098-2825
• DOI: 10.1002/jcla.24535

Objective JKAP modifies T‐cell immune response and inflammation, also involves in cardia‐cerebrovascular disease etiology. This study intended to explore JKAP's relation with T‐helper 1 (Th1), T‐helper 17 (Th17) cell levels, clinical properties, and recurrence‐free survival (RFS) in acute ische...